ESR1 and breast cancer: It offers biomarkers—ER (estrogen receptor), PR (progesterone receptor), and HER2 (human epidermal growth factor receptor 2) —that classify BC into five subtypes (Fig. 1): luminal A and B, HER2 enriched, triple-negative or basal-like (BL), and normal-like BC [8].